Abstract:Objective To explore changes of metabolites in APP/ PS1 double transgenie mice of Alzbeimer disease (AD) by 1H-MR spectroscopy (1H-MRS) and the application value of in early diagnosis of AD.Methods 1H-MRS was performed in 35 APP/PS1 transgenie mice of AD ( study group) and 20 wild type mice ( control group) at age of 3, 6 and 9 months using a 7.0 T MR system.Sub-peak areas of N-acetyl aspartate (NAA), myo-inositol (mI) and creatine (Cr) in the cerebral cortex and hippocampus were measured, and the NAA/Cr and mI/Cr ratios were calculated.The changes in pathology between the two groups were compared.Using the lower limit of 95% confidence interval (CI) of the ml/Cr ratio and the upper limit of 95% CI of the NAA/Cr ratio of AD mice as the threshold, their influences on sensitivity,specificity and accuracy of various age groups of AD animals were compared.Comparison of the 1H-MRS indexes between study mice and wild type mice at each time point were conducted by a two-sample t test.Results The mean mI/Cr ratios of AD mice were 0.68± 0.03, 0.72± 0.04, and 0.77 ± 0.04 respectively at 3, 6 and 9 months of age; while they were 0.63 ± 0.04, 0.64 ± 0.03, and 0.64 ± 0.04 respoetively in control group, the difference was significant ( t = 2.814, 5.146, 14.437, P < 0.01 ).Compared with the control group, the mI/Cr ratio of the 3-month-old AD mice of the study group was significantly increased,and histological examination showed proliferation and activation of neuroglial cells in the cerebral cortex and hippoeampus.The mean NAA/Cr ratio were 1.17 ±0.08, 1.04 ±0.05, and 0.90 ±0.05 respectively at 3,6 and 9 months of age in study group, while they were 1.18 ±0.07, 1.16 ±0.07, and 1.18 ±0.08respectively in control group.There were no significant difference ( t = 0.752, P > 0.05 ) between the study group and control group at 3 months of age, and the NAA/Cr ratio decreased significantly only at 6 and 9 months of age ( t = - 8.514, - 5.646, P < 0.01 ).The immunohistochemical exam demonstrated the appearance of Aβ plaque.According to threshold of mI/Cr, the sensitivity of AD mice of 3, 6 and 9 months of age was 80% (28/35), 84% ( 26/31 ) and 85% ( 23/27 ), and the specificity was 85% ( 17/20 ),94% (17/18) and 100% ( 16/16), and the accuracy was 82% (45/55), 88% (43/49) and 91% (39/43),respectively.For NAA/Cr, the sensitivity of AD mice of 6 and 9 months of age was 84% (26/31) and 89% (24/27), and the specificity was 89% (16/18) and 100% (16/16), and the accuracy was 86% (42/49) and 93% (40/43), respectively.Conclusions NAA and mI are the most sensitive and specific markers for early assessment of AD, and change of mI is earlier than that of NAA.Quantitative analysis of mI may provide important clues for early diagnosis of AD.

Comparison of Diffusion Tensor Imaging and Proton MR Spectroscopy in the Posterior Cingulate of Patients with Alzheimer Disease

Diffusion Tensor Imaging Correlates with Proton Magnetic Resonance Spectroscopy in Posterior Cingulate Region of Patients with Alzheimer’s Disease

[Hydrogen Proton MR Spectroscopy of Posterior Portion Cingulate Gyrus of Patients with Alzheimer's Disease: a Case Control Study].

The Comparitive Study of 1 H-MRS from Cingulate Gyrus in Patients with Mild Cognitive Impairment and Alzheimer's Disease

P2-249: Using brain 3D-MRI and 1H MRS imaging for early diagnosis of Alzheimer's disease

Study of diffusion tensor imaging of posterior cingulate gyrus damage in patients with Alzheimer's disease

Brain Proton Magnetic Resonance Spectroscopy in Mild Cognitive Impairment and Mild Alzheimer Disease

1H-MRS Changes in Mild Cognitive Impairment and Alzheimer's Disease

Correlation Between Anisotropy and Glucose Metabolism Rate in the Posterior Cingulated Gyrus of Patients with Alzheimer's Disease

MR Diffusion Tensor Imaging-Based White Matter Studies in Mild Cognitive Impairment and Alzheimer Disease

Study of Regional Metabolites by Quantitative Proton MR Spectroscopy in APP/PS1 Double Transgenic Alzheimer Disease Mice

Using Proton Magnetic Resonance Spectroscopy to Identify Mild Cognitive Impairment.

Diffusion tensor imaging assessment of white matter microstructure and medial temporal lobe atrophy in patients with mild Alzheimer disease

Magnetic resonance spectroscopy for mild cognitive impairment and Alzheimer's disease

MR diffusion tensor imaging voxel-based analysis of whole brain white matter in patients with amnestic-type mild cognitive impairment and mild Alzheimer disease

[Relationship Between the Data from MR-diffusion Tensor Imaging and the Clinical Cognitive Evaluation in Alzheimer's Disease].

MR Diffusion Tensor Imaging (DTI) and Neuropsychological Testing for Neuronal Connectivity in Alzheimer's Disease (AD) Patients

DTI tract-based analysis in patients with Alzheimer’s disease

Linear Regression Analysis on Diffusion Tensor Imaging with Neuropsychological Study in Patients with Alzheimer's Disease

A comparative study of posterior cingulate metabolism in patients with mild cognitive impairment due to Parkinson's disease or Alzheimer's disease

Analysis of Brain Volumetric and Metabolic Changes with MRI and MRS in Patients with Alzheimer Disease and Normal Elderly